Joel Isaacson & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-9,000
| Closed | -$57K | – | 213 |
|
|
2016
Q4 | $57K | Hold |
9,000
| – | – | 0.01% | 288 |
|
|
2016
Q3 | $40K | Hold |
9,000
| – | – | 0.01% | 361 |
|
|
2016
Q2 | $26K | Hold |
9,000
| – | – | 0.01% | 419 |
|
|
2016
Q1 | $25K | Hold |
9,000
| – | – | 0.01% | 447 |
|
|
2015
Q4 | $93K | Hold |
9,000
| – | – | 0.02% | 244 |
|
|
2015
Q3 | $103K | Sell |
9,000
-3,000
| -25% | -$34.3K | 0.03% | 224 |
|
|
2015
Q2 | $179K | Hold |
12,000
| – | – | 0.05% | 179 |
|
|
2015
Q1 | $108K | Hold |
12,000
| – | – | 0.03% | 247 |
|
|
2014
Q4 | $146K | Hold |
12,000
| – | – | 0.04% | 191 |
|
|
2014
Q3 | $117K | Hold |
12,000
| – | – | 0.04% | 184 |
|
|
2014
Q2 | $153K | Hold |
12,000
| – | – | 0.05% | 157 |
|
|
2014
Q1 | $127K | Hold |
12,000
| – | – | 0.04% | 176 |
|
|
2013
Q4 | $91K | Hold |
12,000
| – | – | 0.03% | 198 |
|
|
2013
Q3 | $87K | Hold |
12,000
| – | – | 0.04% | 193 |
|
|
2013
Q2 | $19K | Buy |
+12,000
| New | +$19K | 0.01% | 329 |
|